Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Zydus Therapeutics Inc.

Clinical trials sponsored by Zydus Therapeutics Inc., explained in plain language.

Now part of Zydus Lifesciences Limited ZYDUSLIFE NSE

US subsidiary of Zydus Lifesciences, developing pharmaceutical products.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2 Terminated 2

Hope for liver disease: new drug trial targets PBC symptoms

Disease control Ongoing

This study tests a drug called saroglitazar magnesium in people with primary biliary cholangitis (PBC), a chronic liver disease. The goal is to see if the drug is safe and helps control the disease. About 102 adults who completed a previous PBC study will take the drug and be mon…

Phase: PHASE3 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:32 UTC